The Latest Breaking News from Piper Sandler

Piper Sandler noted that Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) recently filed 10-K mentions funding of $25 million from a "pharmaceutical company" to run a clinical trial for LUNAR-COV19 vaccine candidate as a booster. 

Piper Sandler raised the price target marginally on Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) to $8.75 from $8.00, with an Overweight rating unchanged.  Catalyst expects FY22 revenue of $195 million - $205 million, driven by transitioning ~125 patients previously on Ruzurgi onto Firdapse, analyst Joseph Catanzaro writes in a research note.  Wall Street's estimate for sales…

China's recent lockdown looks to hamper the online order delivery of global e-commerce firms like Amazon.com Inc (NASDAQ:AMZN) and Walmart Inc (NYSE:WMT), Bloomberg reports. China had to initiate lockdowns and restrictions in its crucial manufacturing hubs like Shenzhen and Dongguan following a Covid-19 resurgence. Related Content: China Restricts Activities In Shenzhen, Shanghai Following Covid-19 Resurgence The…

KeyBanc's Key First Look Data suggested that Apple Inc (NASDAQ: AAPL) tracked slightly better than historical seasonality. The indexed spending was down (9)% month-on-month in February, beating the 3-year average decline of (13)%.

Ameresco Inc (NYSE:AMRC) price target was lowered to $64 (a downside of 7%) from $80 by Piper Sandler analyst Kashy Harrison.  The analyst maintained the Neutral rating on Ameresco shares. Harrison noted that European demand for non-Russian energy supply will "skyrocket." He thinks that the Ukraine crisis boosts demand for renewables/alternatives and is positive for…

Analysts slashed their price targets on Oracle Corp (NYSE:ORCL) post Q3 results. Piper Sandler analyst Brent Bracelin downgraded to Underweight from Neutral with a PT of $70 (8.7% downside), down from $100.  Bracelin found it challenging to reach double-digit organic growth next year, sustaining a cloud shift considering more than 70% of revenue came from the…

Piper Sandler analyst Alexander Potter admitted that the current weekly China Passenger Car Association February sales and production exhibited continued strength for Tesla Inc's (NASDAQ:TSLA) Shanghai factory.  Tesla sold 56,515 China-made vehicles in February, including 33,315 for export. Potter also noticed a "general uptick in inbound calls" from investors regarding Tesla's exposure to geopolitical risks and commodity price…

Palantir Technologies Inc (NYSE: PLTR) is surging Wednesday after Piper Sandler analyst Weston Twigg initiated coverage on the stock with an Overweight rating and a $15 price target.

Analysts continue to see sharp upside in Bumble Inc (NASDAQ:BMBL) despite cutting their price targets post Q4 results. BMO Capital analyst Daniel Salmon upgraded to Outperform from Market Perform with an unchanged price target of $48 (103% upside). Online dating is poised to outperform the internet sector. Cowen analyst John Blackledge raised the price target to $38…

Palantir Technologies Inc. (NYSE: PLTR), while being controversial, has set its sights on achievable growth targets, according to an analyst at Piper Sandler.

Piper Sandler cut its price target on the Meta Platforms Inc (NASDAQ: FB), noting that its advertising headwinds are likely to continue for several months. Analyst Thomas Champion lowered his price target to $240 from $301, implying a 28% upside.